Therma Bright Inc V.THRM

Alternate Symbol(s): TBRIF

Healthcare Medical Devices

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.

TSXV:THRM - Post by User

Therma Bright Inc > Numbers

<< Previous

Bullboard Posts

Next >>

Comment by Vincenzovegaon Mar 24, 2021 1:01pm

159 Views

Post# 32867129

RE:RE:RE:RE:Numbers

Vincenzovega wrote:Smokey, I listen to the video again and he is referring $1.00 per test in production costs, Play it again and you will see what I mean.

He does meantion before that, they will go from sell the device from $30 to $10

Let me know if im right or not... start playing the video at 12:42

He says "get cost down to $2, $2.50 all-in" per test," then he says "if we can get a dollar per test," which is his conservative profit projection.

Obviously if he can get cost down to $2.50 all-in and revenue per test is $10, that leaves $7.50 gross profit per test (from which presumably the reseller gets some).

Regardless of the exact numbers, we are sitting on a potential of a $20 stock by years end.

<< Previous

Bullboard Posts

Next >>

Three micro-cap value stocks trading at peak pessimism